Pricing

Innovent Biologics

1 follower

‌

Innovent Biologics, Inc. is a China-based biopharmaceutical company. The Company's main products include PD-1 antibody; bevacizumab (Avastin) biosimilar, IBI-305; rituximab (MabThera/Rituxan) biosimilar, IBI-301; and adalimumab (Humira) biosimilar, IBI-303.

Industries

Headquarters

Employees

Links

Org chart

Founder, Chairman & CEO

Yu Dechao

Collapse

President

Chief Technology Officer & SVP

Executive Director & CFO

Chief Talent Officer

Blake Salisbury

SVP

SVP, Quality

Astrid Maria Dahl

Chief Operating Officer And Head Of Innovent Biologics (europe)

President

Senior Vice President

Suzhou M1 General Manager, Senior VP

Senior Legal Counsel

Teams

Leadership Team

17 members

Research and Development

7 members

Regulatory and Quality Assurance

6 members

Corporate Strategy and Business Development

4 members

Marketing and Business Development

2 members

Similar companies

Dechra Pharmaceuticals

4 followers

Bristol-Myers Squibb

175 followers

Novartis

224 followers

Viatris

33 followers

Catalent

17 followers

Swedish Orphan Biovitrum

5 followers

Charlie Health

5 followers

Curia Global

4 followers

Roche

236 followers

CAI

2 followers

Precision Medicine Group

2 followers

Explore companies